Herpes simplex virus type 2 serological testing at a community court: Predictors of test acceptance and seropositivity among female defendants

A. M. Roth, B. Van Der Pol, J. D. Fortenberry, M. Reece, B. Dodge, D. Certo, G. D. Zimet

Research output: Contribution to journalArticle

1 Scopus citations


Despite the high prevalence of herpes simplex virus type 2 (HSV-2), testing for asymptomatic infections is uncommon. One population for whom targeted interventions may be prioritized include individuals involved with the correctional system. Here we describe the acceptability of a novel HSV-2 screening program, implemented in a court setting, as a possible intervention for corrections-involved women. Female defendants completed an interviewer administered survey assessing factors associated with uptake/refusal of free point-of-care HSV-2 serologic testing and HSV-2 seropositivity. Participants included 143 women, 18-62 years old (mean 32.85) with diverse ethnicities. The majority (65.7%) accepted testing and 62.4% tested HSV-2 seropositive. Factors independently associated with test acceptance included higher perceived susceptibility to genital herpes infection and not receiving a preventative health screen. Women who were seropositive tended to be older, Black, report having previous STI, and be arrested on a prostitution charge. Findings suggest point-of-care testing in a court setting is acceptable to women and can be implemented to improve case finding of STI.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalInternational Journal of STD and AIDS
Issue number3
StatePublished - Dec 17 2013



  • Community court
  • Genital herpes
  • Herpes simplex virus type 2 (HSV-2)
  • Predictors
  • Seropositivity
  • Sexually transmitted infections
  • Testing

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this